Introduction
The worldwide increasing burden of diabetes mellitus (DM) 1 has shifted patient care from specialists to primary care physicians (PCPs). 2, 3 Proper diagnosis and management of DM is a must for achieving good control of blood glucose and hence preventing complications, particularly microvascular pathologies, associated with significant mortality and morbidity. 4 The pathophysiology of type 2 DM (T2DM) involves defects in both insulin secretion and action, such that insulin secretion in newly diagnosed patients with T2DM drops from 50% to <25% six years after diagnosis. 4 Therefore, optimal glycaemic control in T2DM often eventually requires insulin supplementation therapy, either solely or in combination with other antidiabetic agents. 5 Nevertheless, in clinical practice, many patients with T2DM who could benefit from insulin therapy do not receive it in a timely manner. [6] [7] [8] [9] [10] [11] [12] The latter delay in the initiation and intensification of insulin therapy has been found to be the result of various patient-, physician-and system-related barriers. 7, 8 Patient-related barriers include concerns about insulin side effects (hypoglycaemia and weight gain), its effects on work and social life, fear of injections, feelings of personal failure in effective self-management of T2DM and scepticism about its effectiveness. 7, 8, 13 On the other hand, physician-related barriers contributing to their resistance towards prescribing insulin include the degree of the physician's knowledge of the guidelines, experience with insulin therapy, beliefs and attitudes regarding diabetes management and insulin therapy, as well as perceptions regarding patient's attitudes towards insulin therapy. 2, 7, 9, 13 Physicians with negative personal perceptions towards insulin therapy, such as high concerns about its negative metabolic effects, are probably unwilling to recommend or discuss insulin therapy with their patients. 7, 9 Moreover, physicians who negatively perceive patients' perceptions (e.g. fear of the injection or hypoglycaemia) and attitude towards insulin therapy (e.g. reluctance to start it) will probably identify insulin therapy as a burden and would not be motivated to spend time and resources in order to address patients' concerns and misconceptions about it. 2, 9, 13 In contrast, physicians tend to be less resistant to prescribing insulin and to positively and confidently addressing their patients' concerns if they view insulin as more efficacious and less risky. 7, 9 Unsurprisingly, the extent of physicians' reluctance to initiate or intensify insulin therapy in patients with T2DM varies between countries, mainly in association to both culture and health care system. 9, 13 Therefore, developing appropriate interventions to enhance positive attitudes towards insulin therapy among physicians necessitates the identification of country-specific barriers. 9 In spite of the high rates of T2DM observed among Arab populations in the Middle East, 14 studies related to the knowledge, beliefs, attitudes and practice of physicians towards initiating insulin therapy are scant to almost lacking.
Objectives
The objective of this study was to examine family physicians' attitudes and beliefs towards insulin therapy in patients with T2DM in Arab member countries that constitute the East Mediterranean Region of the World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians (WONCA-EMR).
Research design and methods

Participants
This is a cross-sectional study conducted between April and July 2012 addressing all family physicians practicing in Arab member countries of the WONCA-EMR, namely Bahrain, Egypt, Iraq, Jordan, Lebanon, Oman, Saudi Arabia, Syria and the United Arab Emirates, and whose email addresses are available with their corresponding family medicine societies.
Procedure
The aforementioned target population was invited via emails, followed by two additional 4 weeks spaced email reminders to fill out an anonymous online webbased questionnaire in English.
The approval of the Institutional Review Board at American University of Beirut Medical Center was secured prior to the initiation of the study.
Questionnaire
The questionnaire encompassed items covering demographic characteristics, number of years in family practice, load of patients with T2DM, attitudes, beliefs and perceived barriers of family physicians associated with the initiation of insulin therapy in patients with T2DM (Tables 1-3 ). These items were developed based on a review of the literature 2,7,9,13 and included five-point Likert-type scale questions as well as three multiple choice questions (multiple answers allowed). The latter questions explored the reasons behind physicians' reluctance to initiate insulin. They comprised patient characteristics (e.g. age, weight, past medical history, etc.), physician personal barriers (e.g. outdated, lack of experience with insulin therapy, etc.) and different physicians' beliefs regarding their patients' barriers to insulin therapy.
Data analysis
Data analysis was conducted using SPSS-17. The fivepoint Likert-type scale answers were consolidated into three categories via combining the 'strongly agree' responses with the 'agree' responses and the 'strongly disagree' responses with the 'disagree' responses. Frequency distributions were calculated. Bivariate analyses were conducted using Fisher's exact test, binary logistic regression, Spearman' rho correlation coefficient, Mann-Whitney test or Kruskal-Wallis test in order to evaluate the relation between different attitudes (agree/neutral/disagree), beliefs (agree/ neutral/disagree or yes/no) and the family physicians' characteristics (age in years, number of years of practice, affiliation to an academic institution, average number of patients with T2DM seen per week). Finally backward logistic regressions were performed using the following criteria: probability-of-F-to-enter ≤ 0.050 and probability-of-F-to-remove ≥ 0.100.
Results
Response rates and physicians' characteristics
The invitation email was sent to 348 family physicians with 56 delivery failures. Of the remaining 292 physicians who supposedly received the email, 122 completed the online survey (42%), and of the latter, 95 were affiliated to academic institutions (77.9%), 57 were men (46.7%) and 65 were women (53.2%). The median age of respondents was 42 years, ranging from 27 to 75 years. The number of years in practice varied between 2 and 46 years, with 65% of the respondents reporting to have been in practice for ≥10 years (median: 12). The median number of patients with T2DM seen per week was 15, and the majority of respondents reported working in an urban practice setting (91.5%), with particularly 64.2% reporting urban group practice.
Family physicians' attitudes and beliefs regarding insulin therapy
Respondents (73.6%) reported their preference to delay the initiation of insulin therapy until it is absolutely essential (after trying a combination of several classes of oral hypoglycaemics at maximal doses). Moreover, 59.0% reported that they themselves usually initiate insulin therapy for patients with T2DM, while 34.0% usually refer patients to an endocrinologist. This is intriguing since only 21.6% believed that insulin therapy should be initiated by an endocrinologist and not by a family physician (Table 1) .
Respondents (85.7%) believe that T2DM patients benefit from insulin prior to the development of complications, yet 43.0% of the surveyed physicians reported not believing that most of their patients with T2DM will eventually need to go on insulin regardless of how well they adhere to their treatment regimen ( Table 1) .
The majority of respondents also agreed on the importance (99.1%) and uncomplicatedness (74.7%) of patient education (Table 1) .
However, there was a lack of consensus in the respondents' belief with regards to the degree of difficulty of the initiation of insulin therapy as part of the management of their patients with T2DM. Further beliefs are reported in Table 1 .
Family physicians' preference to delay insulin therapy was found to be significantly associated with referral attitude (Fisher's exact test, P < 0.05), but not with any other item, including physicians' characteristics (age, academic affiliation, years of practice and load of diabetic patients), other beliefs, attitudes and reasons behind reluctance to the initiation insulin therapy (Fisher's exact test, P > 0.05). Family physicians' reluctance to initiate insulin therapy was mainly due to patient rather than physician or staff-related factors as per physicians' opinion ( Table 2) .
The responses of 88% of the surveyed physicians demonstrated conformity and a significant correlation between their belief (of whether the patient should be referred to an endocrinologist for the initiation of insulin therapy) and their practice of referral to an endocrinologist for the initiation of insulin (Fisher's exact test, P < 0.001). The latter belief and practice of referral were also significantly associated with the belief that the initiation of insulin therapy is one of the most difficult aspects of managing patients with T2DM (Fisher's exact test, P < 0.05 and Fisher's exact test, P < 0.01 respectively). In addition, backward regression analyses revealed that physicians' referral attitude was significantly negatively associated with physicians' age and with patients who are ≥75 years of age because of the risk of hypoglycaemia, yet it was positively associated 
with lack of physicians' experience with insulin therapy, their worry about risks associated with insulin therapy and their weekly load of diabetic patients (Table 3) . Table 4 summarizes the main patient barriers to insulin therapy among all physicians (n = 122) as well as those who are reluctant to prescribe insulin due to perceived patient reluctance (n = 77). The statistically significant (Fisher's exact test, P < 0.05) patient-related barriers, as reported by reluctant physicians, included the fear of the injection, hypoglycaemia and weight gain, the perception of the initiation of insulin as a personal failure in controlling T2DM (self-blame), threat to quality of life and the lack of confidence in their ability to manage insulin therapy and adhere to physician's recommendations (Table 4) . Moreover, backward regression analyses showed that patients' perception (as viewed by family physicians) of the initiation of insulin as a personal failure in controlling T2DM (self-blame) and as a threat to their quality of life were the most significant reasons for patient reluctance influencing that of the physicians (Table 4) .
Patients' barriers to insulin therapy in the physicians' opinion
Association between physicians' characteristics and different attitudes and beliefs variables regarding insulin therapy
Age in years, number of years in family practice and weekly load of patients with T2DM turned out to be non-normally distributed. Statistically significant correlations between physicians' characteristics and different attitudes and beliefs variables regarding insulin therapy are reported in Table 5 . Not being affiliated with an academic institution was found to be significantly associated with being reluctant to initiate insulin therapy for patients with T2DM who are ≥75 years of age because of the risk for hypoglycaemia (Fisher's exact test, P > 0.05).
Discussion
The initiation of insulin is considered one of the most difficult aspects of managing patients with T2DM in primary care 7 ; nevertheless, the relevant physician-related barriers have not yet been adequately investigated in different countries, including Arab countries.
Clinical inertia (i.e. inadequate intensification of therapy by the provider) contributes to poor diabetes control in a primary care setting. 15, 16 Similar to PCPs in other countries, most family physician in Arab countries seem to prefer delaying the initiation of insulin treatment until it becomes absolutely necessary, [6] [7] [8] [9] [10] [11] [12] opposite to the greater tendency of specialists for drug intensification. 15 While this attitude has become more acceptable nowadays taking into consideration the different therapeutic options illustrated in the latest position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), 5 it is only permissible for a certain period of time.
The burden of diabetes management in primary care settings is further verified by the rate of referrals Items that remained significant in the final step of backward logistic regression analyses. Insulin therapy attitudes and beliefs of physicians to endocrinologists for insulin initiation, which struck 34% in this study. Also in this study, PCPs clearly lacked consensus regarding the belief that most patients with T2DM will eventually need to go on insulin therapy regardless of how well they adhere to their treatment regimen, a dichotomy that was reported by Hayes et al. 7 and highlighted by Jabbour 17 in his editorial. This may be due to a gap in some physicians' understanding of the natural progression of T2DM or perhaps due to their anticipation of a positive effect of the recently introduced oral anti-diabetic medications in delaying or precluding the need for insulin. However, while the majority of respondents agreed on the benefits of insulin treatment prior to the development of complications, and that its benefits outweigh its risks, this consensus comprised severely obese patients but not the elderly ones due to the fear of 42% of the participants from the risk for hypoglycaemia. This happens to be similar to the results of American PCPs, except that the proportion of PCPs reluctant to initiate insulin therapy in patients with a body mass index (BMI) ≥35 was almost twice that in the current study (27% and 13%, respectively). 7 It is worth noting that the fear of hypoglycaemia in elderly patients was significantly lower among those respondents with an academic position versus others. This may be due to their additional experience in secondary and tertiary care settings, where managing elderly patients with T2DM and other co-morbidities is part of their daily practice and teaching and/or due to their better awareness of up-to-date guidelines. 5 Moreover, when only 63% of the physicians in the current study (compared with 93% in Hayes et al. 7 ) report that they might prescribe insulin more frequently if the route of administration did not involve injections, it can be postulated that new insulin formulations might play a role in overcoming some of the barriers to initiating insulin.
Patient concerns about insulin therapy have been addressed in a number of studies. 9, 13, 18 Patient-related barriers, as viewed by the physicians in this study, including reluctance and perceived fear, seem to outweigh physician-related barriers; for instance, physicians' reluctance to initiate insulin was significantly associated with physician-perceived patients' reluctance ( Table 2) . Most of these findings conform to those of Hayes et al. 7 Hence, this draws our attention to the importance of adopting a patient-centred approach in the treatment of diabetes, as stressed by the ADA and the EASD in their 2012 guidelines. Nevertheless, the latter approach in the management of diabetes requires continuity of care, proper physician training and good communication skills, as well as motivation and confidence in prescribing insulin in order to gain patients' trust overtime and to more appropriately address their fears, concerns and misconceptions appropriately. While Riddle 19 reported that patient training is complicated because of insulin underuse, Hayes et al. 7 reported opposite observations. The latter agree with the results of this study, where most of the surveyed physicians believed that proper patient education is not complicated and that it serves as the key to successful treatment. This belief was significantly positively associated with the physician's experience (i.e. years of practice).
Although insulin reimbursement problems were not investigated in this study, it is interesting to note that the cost of insulin was not among the top patient barriers according to the surveyed physicians, as it was only reported by 15.6% of the surveyed physicians, most of whom (50%) were Lebanese, followed by Syrians. The latter may be due to physicians' lack of adequate awareness of their patients' financial status or of the availability of primary care centres providing insulin therapy for free or at a nominal cost. This necessitates further investigation and appropriate action along with the issue of access to endocrinologists or diabetologists, which may be limited in some Arab countries, particularly in remote areas.
Finally, literature has generally agreed that patient attitudes tend to be affected by those of their physician, such that patients whose health care provider recommended insulin therapy tend to have a more positive attitude towards insulin. 5, 9 It is thus necessary to teach and update physicians on proper diabetes management since medical school, to be followed by enhanced exposure for interns and residents to the outpatient management of diabetes, in addition to continuing education on how to address the different physician-, patient-and system-related barriers. To further improve the quality of diabetes care, the reform must also involve all concerned health care system parties, in an effort to ameliorate outpatient practices infrastructure towards better availability, accessibility and affordability of diabetes medications, including insulin therapy. 20 
Limitations
Stemming from a cross-sectional study, the results of this survey do not allow the interpretation of causal relationships. Moreover, the self-reported data may differ from the actual practice patterns of the participants. Yet, as many studies have demonstrated, there usually is a close link between physician attitudes and behaviour 7 ; we can hence assume that many PCPs in the Arab countries delay insulin prescription in patients with T2DM. Moreover, the patients' views and perceived barriers to the initiation of insulin therapy were not addressed by this study. Finally, these results cannot be generalized to all family physicians in all Arab countries because of the following limitations: (i) the dissemination of invitations to participate via email, as well as to the online survey administration process, targeted only physicians with Internet access; (ii) the majority of the respondents turned out to be affiliated to academic institutions, may be because of their interest in research projects, better awareness of their scientific value, in addition to better Internet access. In addition, this may have constituted a non-response bias as physicians with academic affiliations have more numerous privileges, including their provision with different onsite patient care facilities, multidisciplinary teams, frequent interactions with senior family physicians and other specialists, regular continuing medical education sessions including communication skills, as well as unlimited access to online medical information and (iii) the relatively small sample size that did not allow for the comparison of findings among countries.
Conclusions
Family physicians in the Arab world believe that insulin benefits outweigh its risks and that patient education and training are keys to successful insulin initiation. However, the majority does not believe that most of patients with T2DM will eventually need to go on insulin therapy. In addition, around one-third usually refer their patients with T2DM to endocrinologists for insulin initiation, which constitutes a major primary care practice gap. Continuous comprehensive patient education since the detection of the disease and informal advanced regular PCPs training are highly recommended to improve diabetes care in the Arab world where the prevalence of T2DM is among the highest worldwide. Further studies are needed in each of the participating countries in order to clarify PCPs' as well as diabetic patients' knowledge, attitude and practice towards insulin initiation and to be able to develop appropriate interventions.
